For more than two decades, Truffle Capital has been a leading independent European Business Builder, at the forefront of creating, financing and nurturing innovation, playing a pivotal role in the growth and empowerment of technology leaders in two fields of expertise: Life Sciences (MedTech & Biotech) and Deeptech applied to Finance (Fintech & Insurtech). Truffle Capital's mission is to drive the creation and development of companies on their journey to becoming tomorrow's leaders in BioMedTech and Fintech. Led by its two co-founders and CEOs, Philippe Pouletty, M.D. and Bernard-Louis Roques, Truffle Capital has €500M AuM, raising more than €1.2 Bn since its creation and supporting more than tens of companies with numerous successful exits. In line with its DNA, Truffle acts as a founder systematically in BioMedTech, a lead investor in financing rounds and is proactive in governance.
Looking for a particular Truffle Capital employee's phone or email?
The Truffle Capital annual revenue was $5.9 million in 2026.
Bernard-Louis Roques is the Co-Founder and CEO of Truffle Capital.
36 people are employed at Truffle Capital.
Truffle Capital is based in Paris, 11.
The NAICS codes for Truffle Capital are [52, 523991, 523, 5239, 52399].
The SIC codes for Truffle Capital are [679, 6799, 67].